CSI Market
Sign In | Register

Amneal Pharmaceuticals Inc (AMRX) Annual Income Statement

Annual · GAAP · USD millions
Access AMRX quarterly income statements →
The income statement data below highlights shifts in Amneal Pharmaceuticals Inc's operating performance over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
2025 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax3,018.76
Total Revenue3,018.31
Costs & Expenses
Cost of Goods and Services Sold1,905.00
Gross Profit1,113.31
Selling, Administration, Marketing526.83
Research and Development Expense186.18
Restructuring, Accretion & Impairment Charges3.82
Other Operating Expense / -Income-5.24
Total operating costs including COS2,624.21
Operating income / -loss394.10
Interest Expense241.09
Net Interest Expense / -Income241.09
Extinguishment of Debt31.37
Foreign Currency Transaction Gain (Loss), before Tax-7.64
Other loss / -income-16.52
Total costs & expenses2,879.10
Income & Taxes
Income / -loss before income taxes139.21
Income taxes expenses / -benefit11.28
Income after income taxes127.93
Net income / -loss of other equity0.00
Income / -loss from continuing operations127.93
Non-controlling interests-55.88
Preferred dividends0.00
Net income / -loss127.93
Income / -loss to shareholder72.06
EBIT380.30
EBITD380.30
EBITDA402.73
Earnings Per Share
Basic EPS (excl. extra items)0.23
Basic Net EPS0.23
Basic shares outstanding (Mill. of Units)313.37
Diluted Net EPS0.22
Diluted average shares (Mill. of Units)324.81
4 historic quarters locked

Sign in to unlock the full Amneal Pharmaceuticals Inc income statement history.

Sign In Create Free Account

About Amneal Pharmaceuticals Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: February 27, 2026
  • Original filing: amrx-20251231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.